These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 25940339)

  • 41. Hormone receptor expression in breast cancer: postanalytical issues.
    Lee M; Lee CS; Tan PH
    J Clin Pathol; 2013 Jun; 66(6):478-84. PubMed ID: 23526546
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of HER2/neu Status by Immunohistochemistry Using Computer-Based Image Analysis and Correlation With Gene Amplification by Fluorescence In Situ Hybridization Assay: A 10-Year Experience and Impact of Test Standardization on Concordance Rate.
    Sarode VR; Xiang QD; Christie A; Collins R; Rao R; Leitch AM; Euhus D; Haley B
    Arch Pathol Lab Med; 2015 Jul; 139(7):922-8. PubMed ID: 26125432
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Human epidermal growth factor receptor 2 expression in breast cancer: correlation with clinical pathological features.
    Ning SF; Li JL; Luo CP; Wei CH; Lu YK; Liu HZ; Wei WE; Zhang LT
    Int J Clin Exp Pathol; 2014; 7(12):8740-7. PubMed ID: 25674240
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Development and evaluation of a novel RT-qPCR based test for the quantification of HER2 gene expression in breast cancer.
    El Hadi H; Abdellaoui-Maane I; Kottwitz D; El Amrani M; Bouchoutrouch N; Qmichou Z; Karkouri M; ElAttar H; Errihani H; Fernandez PL; Bakri Y; Sefrioui H; Moumen A
    Gene; 2017 Mar; 605():114-122. PubMed ID: 28039034
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Quantitative determination of estrogen receptor, progesterone receptor, and HER2 mRNA in formalin-fixed paraffin-embedded tissue--a new option for predictive biomarker assessment in breast cancer.
    Müller BM; Kronenwett R; Hennig G; Euting H; Weber K; Bohmann K; Weichert W; Altmann G; Roth C; Winzer KJ; Kristiansen G; Petry C; Dietel M; Denkert C
    Diagn Mol Pathol; 2011 Mar; 20(1):1-10. PubMed ID: 21326033
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections.
    Shi SR; Key ME; Kalra KL
    J Histochem Cytochem; 1991 Jun; 39(6):741-8. PubMed ID: 1709656
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of neoadjuvant chemotherapy on expressions of estrogen receptor, progesterone receptor, human epidermal growth factor receptor 2, and Ki-67 in breast cancer.
    Qin Q; Gao F; Jiang W; Tan Q; Mo Q; Wei C
    Chin Med J (Engl); 2014; 127(18):3272-7. PubMed ID: 25266526
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Comparison of touch imprint cytology of core needle biopsy and section histopathology in breast cancer diagnosis].
    Zhang ZH; Zhao LL; Guo HQ; Zheng S; Zhang BL; Xu XZ; Pan QJ; Zhang BN
    Zhonghua Zhong Liu Za Zhi; 2010 Dec; 32(12):921-6. PubMed ID: 21223801
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effect of prolonged fixation on the immunohistochemical evaluation of estrogen receptor, progesterone receptor, and HER2 expression in invasive breast cancer: a prospective study.
    Tong LC; Nelson N; Tsourigiannis J; Mulligan AM
    Am J Surg Pathol; 2011 Apr; 35(4):545-52. PubMed ID: 21358301
    [TBL] [Abstract][Full Text] [Related]  

  • 50. HER2 immunohistochemical assessment with A0485 polyclonal antibody: is it time to refine the scoring criteria for the "2+" category?
    Pennacchia I; Vecchio FM; Carbone A; Arena V
    Appl Immunohistochem Mol Morphol; 2015 Jan; 23(1):31-5. PubMed ID: 25356940
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [A simplified way of applying positive controls in immunohistochemistry].
    Chen SP; Ding Y; Gao MQ
    Zhonghua Bing Li Xue Za Zhi; 2006 Nov; 35(11):693-4. PubMed ID: 17374219
    [No Abstract]   [Full Text] [Related]  

  • 52. Standardizing slide-based assays in breast cancer: hormone receptors, HER2, and sentinel lymph nodes.
    Ross JS; Symmans WF; Pusztai L; Hortobagyi GN
    Clin Cancer Res; 2007 May; 13(10):2831-5. PubMed ID: 17504980
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Loss of antigenicity in stored sections of breast cancer tissue microarrays.
    Fergenbaum JH; Garcia-Closas M; Hewitt SM; Lissowska J; Sakoda LC; Sherman ME
    Cancer Epidemiol Biomarkers Prev; 2004 Apr; 13(4):667-72. PubMed ID: 15066936
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Consistency of staining and reporting of oestrogen receptor immunocytochemistry within the European Union--an inter-laboratory study.
    Wells CA; Sloane JP; Coleman D; Munt C; Amendoeira I; Apostolikas N; Bellocq JP; Bianchi S; Boecker W; Bussolati G; Connolly CE; Dervan P; Drijkoningen M; Ellis IO; Elston CW; Eusebi V; Faverly D; Heikkila P; Holland R; Jacquemier J; Lacerda M; Martinez-Penuela J; De Miguel C; Peterse JL; Rank F; Reiner A; Saksela E; Sigal-Zafrani B; Sylvan M; Borisch B; Cserni G; Decker T; Kerner H; Kulka J; Regitnig P; Sapino A; Tanous AM; Thorstenson S; Zozaya E;
    Virchows Arch; 2004 Aug; 445(2):119-28. PubMed ID: 15221370
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunochemistry for oestrogen receptor, progesterone receptor and HER2 on cell blocks in primary breast carcinoma.
    Kumar SK; Gupta N; Rajwanshi A; Joshi K; Singh G
    Cytopathology; 2012 Jun; 23(3):181-6. PubMed ID: 21375607
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Short-term outcome of primary operated early breast cancer by hormone and HER-2 receptors.
    Brouckaert O; Pintens S; Van Belle V; Van Huffel S; Camerlynck E; Amant F; Leunen K; Smeets A; Berteloot P; Van Limbergen E; Decock J; Hendrickx W; Weltens C; Van den Bogaert W; Vanden Bempt I; Drijkoningen M; Paridaens R; Wildiers H; Vergote I; Christiaens MR; Neven P
    Breast Cancer Res Treat; 2009 May; 115(2):349-58. PubMed ID: 18629635
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of two antibodies for evaluation of estrogen receptors in paraffin-embedded tumors.
    Hendricks JB; Wilkinson EJ
    Mod Pathol; 1993 Nov; 6(6):765-70. PubMed ID: 7508117
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Study of interlaboratory reliability and reproducibility of estrogen and progesterone receptor assays in Europe. Documentation of poor reliability and identification of insufficient microwave antigen retrieval time as a major contributory element of unreliable assays.
    Rhodes A; Jasani B; Balaton AJ; Barnes DM; Anderson E; Bobrow LG; Miller KD
    Am J Clin Pathol; 2001 Jan; 115(1):44-58. PubMed ID: 11190807
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prognostic and predictive significance of ErbB-2 breast tumor levels measured by enzyme immunoassay.
    Eppenberger-Castori S; Kueng W; Benz C; Caduff R; Varga Z; Bannwart F; Fink D; Dieterich H; Hohl M; Müller H; Paris K; Schoumacher F; Eppenberger U
    J Clin Oncol; 2001 Feb; 19(3):645-56. PubMed ID: 11157014
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tissue microarray-based immunohistochemical study can significantly underestimate the expression of HER2 and progesterone receptor in ductal carcinoma in situ of the breast.
    Lin Y; Hatem J; Wang J; Quinn A; Hicks D; Tang P
    Biotech Histochem; 2011 Oct; 86(5):345-50. PubMed ID: 20701550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.